SCHEMBL29005482

SCHEMBL29005482

CC(=O)N(c1cccc(Cl)c1)c1cc([N+](=O)[O-])ccn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
TDP1 Q9NUW8 1/20 0.46
SMN1; SMN2 Q16637 6/20 0.45
LMNA P02545 4/20 0.45
MAPT P10636 2/20 0.45
NPC1 O15118 1/20 0.45
HTT P42858 1/20 0.45
RAB9A P51151 1/20 0.45
ATM Q13315 1/20 0.45
TP53 P04637 1/20 0.40
CRHR1 P34998 1/20 0.39
P2RX4 Q99571 2/20 0.38
ALOX5 P09917 1/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
KEAP1 Q14145 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30285884 1.00 ALDH1A1 (0.46) ALDH1A1TDP1SMN1; SMN2LMNAMAPT
SCHEMBL30285745 0.86 TP53 (0.47) ALDH1A1SMN1; SMN2LMNAMAPTNPC1
SCHEMBL29005766 0.86 MEN1 (0.45) ALDH1A1TDP1SMN1; SMN2LMNAMAPT
SCHEMBL30285811 0.86 MEN1 (0.45) ALDH1A1TDP1SMN1; SMN2LMNAMAPT
SCHEMBL29005449 0.85 HTT (0.44) ALDH1A1SMN1; SMN2LMNAMAPTNPC1
SCHEMBL30285730 0.85 HTT (0.44) ALDH1A1SMN1; SMN2LMNAMAPTNPC1
SCHEMBL29005476 0.84 TP53 (0.36) ALDH1A1TDP1SMN1; SMN2LMNAMAPT
SCHEMBL30285840 0.84 TSHR (0.40) ALDH1A1SMN1; SMN2MAPTNPC1HTT
SCHEMBL30285721 0.84 TP53 (0.36) ALDH1A1TDP1SMN1; SMN2LMNAMAPT
SCHEMBL29005628 0.84 TSHR (0.40) ALDH1A1SMN1; SMN2MAPTNPC1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115996911-A Substituted N-phenylacetamides having P2X4 receptor antagonistic activity 拜耳公司 2023-04-21 CN disclosed